Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Capital Expenditures came in at $9.0 million in Q2 2026, up 20.0% YoY from $7.5 million in Q2 2025, and up 12.5% on a QoQ basis from $8.0 million in Q1 2026.
Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Capital Expenditures data on file, last reported at $9.0 million in Q2 2026.
- Quarterly Capital Expenditures rose 20.0% year-over-year to $9.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $31.8 million (up 106.49% YoY) and the FY2025 annual result came in at $25.2 million, down 1.18% from the prior year.
- Capital Expenditures grew to $9.0 million in Q2 2026, from $8.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $18.4 million in Q4 2022 to a low of -$3.2 million in Q4 2024.
- A 5-year average of $9.0 million and a median of $8.6 million in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures tumbled 134.04% — and 2025, when it jumped 334.38%.
- Tracing FTRE's Capital Expenditures over 5 years: stood at $18.4 million in 2022, then tumbled by 48.91% to $9.4 million in 2023, then plunged by 134.04% to -$3.2 million in 2024, then jumped by 334.38% to $7.5 million in 2025, then rose by 20.0% to $9.0 million in 2026.
- The last three Capital Expenditures figures came in at $9.0 million (Q2 2026), $8.0 million (Q1 2026), and $7.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.30 Mn |